Vaxcyte Inc (PCVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $10.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
Vaxcyte Inc (PCVX) Competitors
The companies most similar to Vaxcyte are Abivax SA American Depositary Shares (ABVX), Immunovant (IMVT) and Cytokinetics (CYTK). By market cap, Vaxcyte ranks 3rd of the 13 companies on this page; Exelixis (EXEL) is the largest at $16.84B. The median P/E of the 4 companies with a P/E is 34.1x.
Peer Comparison
PCVX's revenue growth of 0.0% is below the peer median of 20.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Vaxcyte (PCVX) | $10.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Abivax SA American Depositary Shares (ABVX) | $7.67B | N/A | N/A | 0.0% | -159.6% | -6.8% | 0.00% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cytokinetics Inc (CYTK) | $7.82B | N/A | 65.3x | 0.0% | -66.0% | 2357.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Immunitybio Inc (IBRX) | $6.40B | N/A | 30.3x | 0.0% | -780.5% | 52.3% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| CG Oncology, Inc. Common stock (CGON) | $6.65B | N/A | N/A | 0.0% | -21.1% | -3.7% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Spyre Therapeutics Inc. (SYRE) | $9.88B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Axsome Therapeutics Inc (AXSM) | $7.45B | N/A | 8.6x | -18.2% | -48.1% | 51.9% | 0.00% |
| Exelixis Inc (EXEL) | $16.84B | 19.3x | 6.9x | 35.4% | N/A | 10.2% | 0.00% |
| Peer median | $8.18B | 34.1x | 15.8x | 0.0% | -57.0% | 20.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Vaxcyte, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Abivax SA American Depositary Shares (ABVX) | Abivax SA is a clinical-stage biotechnology firm focused on pioneering immunotherapies for chronic inflammatory diseases and viral infections. | ABVX competitors |
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| Cytokinetics Inc (CYTK) | Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering... | CYTK competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Immunitybio Inc (IBRX) | ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose... | IBRX competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
| CG Oncology, Inc. Common stock (CGON) | CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070... | CGON competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Spyre Therapeutics Inc. (SYRE) | Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by... | SYRE competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Axsome Therapeutics Inc (AXSM) | Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United... | AXSM competitors |
| Exelixis Inc (EXEL) | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development... | EXEL competitors |
Frequently Asked Questions About PCVX
Who are Vaxcyte's main competitors?
The companies most similar to Vaxcyte include Abivax SA American Depositary Shares (ABVX), Immunovant (IMVT), Cytokinetics (CYTK), TG Therapeutics (TGTX) and Immunitybio (IBRX), listed from the closest match.
Who is Vaxcyte's biggest competitor?
Exelixis (EXEL) is the largest of the similar companies at $16.84B; Abivax SA American Depositary Shares (ABVX) is the closest match by business profile, size, sector and industry.
How does PCVX stock compare with its competitors?
PCVX's net margin is 0.0% against a peer median of 0.0%.
Which of Vaxcyte's competitors pays a higher dividend?
Vaxcyte pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Vaxcyte bigger than its competitors?
No. Vaxcyte is 3rd by market cap among the 13 companies on this page; the largest is Exelixis (EXEL) at $16.84B.
PCVX pages: Overview, Earnings, Forecast, Financials, Competitors